文献速递针灸推拿中医康复

电针通过EphBs-p38 MAPK通路及抑制小胶质细胞缓解神经病理性疼痛

Analgesic effects of electroacupuncture via the EphBs-p38 MAPK signaling pathway and microglial suppression in the chronic constriction injury rat model of neuropathic pain.
PubMed 文献 · Acupunct Med · 2025-08-23

该研究在慢性坐骨神经缩窄损伤(CCI)大鼠模型中探讨电针(EA)的镇痛效应及其与EphBs-p38 MAPK通路和小胶质细胞的关系。结果显示,CCI引起痛觉过敏、p38 MAPK磷酸化及小胶质细胞活化增加,而p38 MAPK抑制剂SB203580和EphBs抑制剂EphB1-Fc可逆转这些效应;电针表现出类似有益效应,但被p38 MAPK激动剂anisomycin和EphBs激动剂EphrinB1-Fc所抵消。结论提示电针镇痛作用与降低p-p38 MAPK表达及后续小胶质细胞失活相关,电针可能作为神经病理性疼痛的补充疗法。

要点

  • 电针可减轻CCI大鼠的痛觉过敏,效应与抑制p38 MAPK磷酸化相关。
  • EphBs抑制剂EphB1-Fc模拟电针效应,EphBs激动剂则抵消电针效应。
  • p38 MAPK激动剂anisomycin可抵消电针的镇痛作用。

核心结论

  • 电针在CCI大鼠神经病理性疼痛模型中的镇痛效应与降低p-p38 MAPK表达及后续小胶质细胞失活相关。
  • 电针可能作为神经病理性疼痛的补充疗法。

研究设计与样本

  • 60只雄性Sprague Dawley(SD)大鼠,分为两个实验,每组n=6。
  • 实验1:CCI前分别鞘内注射SB203580(p38 MAPK抑制剂)、肌内注射EphB1-Fc(EphBs抑制剂)或不注射。
  • 实验2:CCI模型大鼠接受电针单独或联合anisomycin(p38 MAPK激动剂)或EphrinB1-Fc(EphBs激动剂),并与最小针刺(MA)对照。
  • 两个实验均设假手术组作为CCI对照。

主要发现

  • CCI诱导行为学痛觉过敏,表现为缩足潜伏期(PWL)、缩足阈值(PWT)及细胞因子水平改变,并增加p38 MAPK磷酸化和小胶质细胞活化。
  • SB203580和EphB1-Fc可逆转CCI引起的上述效应。
  • 电针表现出与抑制剂类似的有益效应,但联合anisomycin或EphrinB1-Fc时被抵消。

临床怎么用

  • 动物实验提示电针可能通过抑制EphBs-p38 MAPK通路和小胶质细胞活化发挥神经病理性疼痛镇痛作用。
  • 临床转化前需进一步验证电针在神经病理性疼痛患者中的疗效及通路相关性。

局限性

  • 研究为动物实验,样本量每组n=6,结论外推至临床需谨慎。
  • 未报告具体行为学与分子指标的数值及统计检验结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To explore the analgesic effects of electroacupuncture (EA) and its impact on the EphBs-p38 mitogen-activated protein kinase (MAPK) pathway and microglia in a rat model of neuropathic pain (NP). METHODS: Following adaptive training, 60 male Sprague Dawley (SD) rats were allocated to one of two experiments. In experiment 1, rats received intrathecal SB203580 (p38 MAPK inhibitor), intramuscular EphB1-Fc (EphBs inhibitor) or no injection before undergoing chronic constrictive injury (CCI). In experiment 2, CCI model rats received EA either alone or combined with either anisomycin (p38 MAPK agonist) or EphrinB1-Fc (EphBs agonist) versus minimal acupuncture (MA) as a control intervention. A sham surgery group was included in both experiments as a control for CCI. All groups consisted of n = 6 rats (four in experiment 1 and six in experiment 2). Behavioral hyperalgesia was examined and the spinal L5-6 region was harvested and subjected to enzyme-linked immunosorbent assay to assess tumor necrosis factor (TNF)-α and interleukin (IL)-1β levels. Western blotting and immunofluorescence were used to assess protein expression of B-cell lymphoma (Bcl)-2, Bcl-2 associated X-protein (BAX), EphB1, EphrinB1, p38 MAPK, phosphorylated (p)-p38 MAPK and ionized calcium binding adaptor molecule (Iba)-1. RESULTS: CCI induced behavioral hyperalgesia, as demonstrated by altered paw withdrawal latency (PWL), paw withdrawal threshold (PWT) and cytokine levels, and increased p38 MAPK phosphorylation and microglial activation. However, inhibitors SB203580 and EphB1-Fc reversed these effects. Notably, EA showed similar beneficial effects, but these were counteracted when combined with anisomycin and EphrinB1-Fc. CONCLUSIONS: The analgesic effects of EA in this rat model of NP appear to be linked to diminished p-p38 MAPK expression and subsequent microglial deactivation. EA has a potential role as a complementary therapy for NP.

来源:Acupunct Med,查看原文。版权归原作者所有。

引用

  1. Ying Y, Yang G, Li X, et al. Analgesic effects of electroacupuncture via the EphBs-p38 MAPK signaling pathway and microglial suppression in the chronic constriction injury rat model of neuropathic pain. Acupunct Med. 2025. PMID: 40847801. doi:10.1177/09645284251363987

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。